Safety and effectiveness of eculizumab in Japanese patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: interim analysis of post-marketing surveillance data

被引：0
|
作者：
Nakashima, I. [1 ]
Hoshino, Y. [2 ]
Okamura, K. [2 ]
Kikui, H. [2 ]
机构：
[1] Tohoku Med & Pharmaceut Univ, Div Neurol, Sendai, Miyagi, Japan
[2] Alex Pharma GK, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P973
引用
收藏
页码：791 / 792
页数：2
相关论文
共 50 条
  • [41] Aquaporin-4 antibody-positive patients may not always fulfil the clinical criteria for neuromyelitis optica
    Heather Wood
    Nature Reviews Neurology, 2013, 9 (7) : 360 - 360
  • [42] Editorial on: Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder
    Pardo, Santiago
    Giovannoni, Gavin
    Hawkes, Christopher
    Lechner-Scott, Jeannette
    Waubant, Emmanuelle
    Levy, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : A1 - A2
  • [43] Aquaporin-4 antibody seroreversion in patients with neuromyelitis optica spectrum disorder treated with rituximab
    Rammohan, K.
    Tornes, L.
    Delgado, S.
    Garg, N.
    Dixon, C.
    Ortega, M.
    Hernandez, J.
    Hughes, N.
    Botero, M.
    Mccarthy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 444 - 445
  • [44] Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with cholangiocarcinoma: Casual or causal association?
    Fang, Wei
    Tang, Jin-Long
    Lin, Bin
    Lai, Qi-Lun
    Cai, Meng-Ting
    Liu, Zhi-Rong
    Zhang, Yin-Xi
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (02) : 749 - 751
  • [45] Long-term Safety and Efficacy of Eculizumab in Asian Patients With Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
    Fujihara, K.
    Berthele, A.
    Kim, H. J.
    Levy, M.
    Palace, J.
    Nakashima, I.
    Totolyan, N.
    Viswanathan, S.
    Wang, K-C.
    Pace, A.
    Armstrong, R.
    Carrillo-Infante, C.
    Miller, L.
    Wingerchuk, D. M.
    Pittock, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP84 - NP85
  • [46] Safety and Effectiveness of Eculizumab for Patients with Generalized Myasthenia Gravis in Japan: Interim Analysis of Post-Marketing Surveillance
    Murai, H.
    Suzuki, S.
    Hasebe, M.
    Fukamizu, Y.
    Rodrigues, E.
    Utsugisawa, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 485 - 486
  • [47] DIFFERENCES IN DISEASE PATTERNS BETWEEN AQUAPORIN-4 ANTIBODY-POSITIVE AND ANTIBODY-NEGATIVE PATIENTS WITH NEUROMYELITIS OPTICA
    Kim, S.
    Traboulsee, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 148 - 148
  • [48] Rheumatoid arthritis with aquaporin-4 antibody-positive neuromyelitis optica receiving rituximab therapy
    Wang, Chrong Reen
    Hsu, Sheng-Min
    Chen, Ying-Chen
    ARCHIVES OF RHEUMATOLOGY, 2022, 37 (01) : 153 - 155
  • [49] Differences in Disease Patterns between Aquaporin-4 Antibody-Positive and Antibody-Negative Patients with Neuromyelitis Optica
    Kim, Rachel
    Kuan, Annie
    Fujihara, Kazuo
    Takahaski, Toshiyuki
    Traboulsee, Anthony
    NEUROLOGY, 2013, 80
  • [50] Serum biomarkers and patient age in multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
    Lee, Eun-Jae
    Lim, Young-Min
    Kim, Seungmi
    Choi, Lyn Kyung
    Kim, Hyunjin
    Kim, Seung Min
    Kim, Geonwoo
    Kim, Hyewon
    Lee, Seulki
    Kim, Kwang-kuk
    NEUROLOGY, 2020, 94 (15)
12345